Beacon Pointe Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$297K Buy
2,252
+132
+6% +$15.3K 0.05% 218
2019
Q3
$238K Sell
2,120
-4,613
-69% -$514K 0.05% 232
2019
Q2
$710K Buy
6,733
+748
+12% +$88.1K 0.15% 129
2019
Q1
$718K Buy
5,985
+1,199
+25% +$146K 0.16% 119
2018
Q4
$555K Buy
+4,786
New +$535K 0.2% 121

Other funds holding LLY

Beacon Pointe Wealth Advisors's LLY Position: Q4 2019 in Review

Beacon Pointe Wealth Advisors increased its Eli Lilly (LLY) stake by 6.2% in Q4 2019, buying an estimated $15.3K and bringing the position to 2,252 shares worth $297K. The position accounts for 0.05% of the portfolio, ranked #218.

Beacon Pointe Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 5 quarters since. The position peaked at $718K in Q1 2019. 1,672 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Beacon Pointe Wealth Advisors held 2,252 shares of Eli Lilly worth $297K as of Q4 2019.
  • Beacon Pointe Wealth Advisors bought 132 Eli Lilly shares in Q4 2019, an estimated $15.3K.
  • Eli Lilly made up 0.05% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #218 holding.
  • Beacon Pointe Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 5 quarters since.
  • Beacon Pointe Wealth Advisors's Eli Lilly position peaked at $718K in Q1 2019.
  • 1,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.